3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Tamoxifen
10
Capecitabine
10
Trastuzumab
9
Docetaxel
9
pyrotinib
7
Exercise
7
Control Groups
7
Vinorelbine
6
Paclitaxel
6
Letrozole
6
Gemcitabine
6
Cyclophosphamide
6
Carboplatin
6
exemestane
5
Indocyanine Green
5
Anastrozole
5
pertuzumab
4
dalpiciclib
4
Injections
4
Fulvestrant
4
Doxorubicin
4
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy
3
Radiation
3
Mammography
3
Epirubicin
3
Drug Therapy
3
Cisplatin
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Alendronate
×
Breast
×
Clear all
NCT00122356
2013-03-13
BATMAN
Barwon Health
Phase 3
Completed
303 enrolled